Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Urology and Nephrology
Published in: International Urology and Nephrology 8/2015

01-08-2015 | Nephrology - Letter to the Editor

Late onset of progressive speech impairment due to tacrolimus-associated leukoencephalopathy after kidney transplantation

Authors: Kazushige Sato, Yuichi Miura, Yuhji Marui, Kiho Tanaka, Shinji Tomikawa

Published in: International Urology and Nephrology | Issue 8/2015

Login to get access

Excerpt

Editor, …
Literature
1.
Reyes J, Gayowski T, Fung J, Todo S, Alessiani M, Starzl TE (1990) Expressive dysphasia possibly related to FK506 in two liver transplant recipients. Transplantation 50:1043–1045PubMedCentralPubMedCrossRef
2.
Boeve BF, Kimmel DW, Aronson AE, de Groen PC (1996) Dysarthria and apraxia of speech associated with FK-506 (tacrolimus). Mayo Clin Proc 71:969–972PubMedCrossRef
3.
Bronster DJ, Gurkan A, Buchsbaum MS, Emre S (2000) Tacrolimus-associated mutism after orthotopic liver transplantation. Transplantation 70:979–982PubMedCrossRef
4.
Sokol DK, Molleston JP, Filo RS, Van Valer J, Edwards-Brown M (2003) Tacrolimus (FK506)-induced mutism after liver transplant. Pediatr Neurol 28:156–158PubMedCrossRef
5.
Sierra-Hidalgo F, Martínez-Salio A, Moreno-García S, de Pablo-Fernández E, Correas-Callero E, Ruiz-Morales J (2009) Akinetic mutism induced by tacrolimus. Clin Neuropharmacol 32:293–294PubMedCrossRef
6.
Vearrier D, Simpson SE, Greenberg MI (2011) Mutism and persistent dysarthria due to tacrolimus-based immunosuppression following allogeneic liver transplantation. Am J Ther 18:e274–e276PubMedCrossRef
7.
Toledo Perdomo K, Navarro Cabello MD, Pérez Sáez MJ, Ramos Pérez MJ, Agüera Morales ML, Aljama García P (2012) Reversible acute encephalopathy with mutism, induced by calcineurin inhibitors after renal transplantation. J Nephrol 25:839–842PubMedCrossRef
8.
Bilbao I, Dopazo C, Castells L, Lazaro J, Caralt M, Sapisochin G, Charco R (2014) Immunosuppression based on everolimus in liver transplant recipients with severe early post-transplantation neurotoxicity. Transplant Proc 46:3104–3107PubMedCrossRef
9.
Jeng KS, Chu SH, Huang CC, Lin CK, Lin CC, Chen KH (2014) Loss of speech after living-related donor liver transplantation: detection of the lesion by diffusion tensor image. Transplant Proc 46:880–882PubMedCrossRef
Metadata
Title
Late onset of progressive speech impairment due to tacrolimus-associated leukoencephalopathy after kidney transplantation
Authors
Kazushige Sato
Yuichi Miura
Yuhji Marui
Kiho Tanaka
Shinji Tomikawa
Publication date
01-08-2015
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 8/2015
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-015-1026-9

Other articles of this Issue 8/2015

International Urology and Nephrology 8/2015 Go to the issue

Urology - Original Paper

Decellularized dermal strip as a suburethral sling in a rat model of stress urinary incontinence

Urology - Original Paper

Evaluation of oxidative stress status and antioxidant capacity in patients with painful bladder syndrome/interstitial cystitis: preliminary results of a randomised study

Urology - Original Paper

MRI factors to predict urinary incontinence after retropubic/laparoscopic radical prostatectomy

Nephrology - Original Paper

Serum paraoxonase activity is associated with epicardial fat tissue in renal transplant recipients

Nephrology - Original Paper

Renal biopsy in the elderly: a single-center experience

Urology - Original Paper

A novel rat model of catheter-associated urinary tract infection
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits